Rüdersdorf

Germany

7 total trials 3 recruiting

Filter these 7 trials by phase, condition, sponsor and more.

Open in Search →

BETRI-Prospective: Asthma control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 µg]) vs Single Inhaler ICS/LABA (200/ … Pending

2025-524289-56-00 6 Asthma
Phase IB open label, long-term, extension basket trial of RAY121 to inhibit classical complement pathway in immunological diseases (RAINBOW- … Recruiting

2024-511346-39-00 3 2025-03-28 Immune-mediated necrotizing myopathy
Elacestrant versus Standard Endocrine Therapy in Women and Men with Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast C … Recruiting

2024-515445-42-00 5 2025-03-24 Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast
Phase Ib Open Label Basket Trial of RAY121 to Inhibit Classical Complement Pathway in Immunological Diseases (RAINBOW Trial) Recruiting

2023-507692-21-00 3 2024-08-22 Bullous pemphigoid
OCEAN(a)-Outcomes – Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction – Outcomes trial Ended recruitment

2022-501608-85-00 5 2023-05-09 Cardiovascular disease (atherosclerotic cardiovascular disease (ASCVD)
Efficacy and Safety Study of Nipocalimab for Adults with Active Inflammatory Myopathies Ended recruitment

2023-505314-20-00 4 2023-01-20 Active Idiopathic Inflammatory Myopathies (IIM)
A randomized, multicenter, open-label trial comparing the effectiveness of Inclisiran to bempedoic acid on LDL cholesterol (LDL-C) lowering … Ended

2024-511076-32-00 6 2024-06-21 Hypercholesterolemia

Showing 1–7 of 7 trials